Innovative Transdermal Drug Delivery. Faster, Safer, Smarter Therapies

Anziva Pharmaceuticals, founded by Dr. Simerdeep Singh Gupta, is reimagining how drugs are delivered. From lab to patient, we focus on transforming proven therapies into safer and more effective solutions that reach patients faster.

Our science builds on what already works. Using the FDA 505(b)(2) pathway, we redesign existing drugs into advanced formulations that reduce cost, accelerate approval, and create real impact with fewer risks.

Our pipeline is advancing solutions for major unmet needs, including non opioid pain relief patches and innovative trauma care products. Each program follows a clear regulatory path and is designed to improve patients’ lives while creating strong commercial opportunities.